Many human diseases owe their pathology, to some degree, to the erroneous conversion of proteins from their soluble state into fibrillar, β-structured aggregates, often referred to as amyloid fibrils. Neurodegenerative diseases, such as Alzheimer and spongiform encephalopathies, as well as type 2 diabetes and both localized and systemic amyloid osis, are among the conditions that are associated with the formation of amyloid fibrils. Several mathe matical tools can rationalize and even predict important para meters of amyloid fibril formation. It is not clear, however, whether such algorithms have predictive powers for in vivo systems, in which protein aggregation is affected by the presence of other biological factors. In this review, we briefly describe the existing algorithms and use them to predict the effects of mutations on the aggregation of specific proteins, for which in vivo experimental data are available. The comparison between the theoretical predictions and the experimental data obtained in vivo is shown for each algorithm and experimental data set, and statistically significant correlations are found in most cases.
Introduction
Biological fluids-be they bacterial or eukaryotic cytosols, or the plasma of superior mammals-are colloidal, aqueous solutions in which various proteins are present at high concentrations. one of the properties of a colloidal solution is the aggregation of its constituent particles into large assemblies that affect cell and tissue function. in the case of peptides and proteins, the resulting aggregates generally consist of well-organized fibrillar assemblies, often referred to as amyloid fibrils. in these structures the various polypeptide chains are held together by continuous β-sheet structures running along the fibrils, in which the β-strands are perpendicular to the fibril axes (chiti & Dobson, 2006) .
From a physicochemical perspective, amyloid fibril formation represents an essential feature of the behaviour of poly peptide chains. understanding this behaviour is vital for a thorough character ization of the nature of proteins-for example to decipher their folding code-and is a worthwhile pursuit, even without reference to human disease (Jahn & radford, 2008) . in addition, aggregation is a problem in biotechnology, in which the large-scale expression of proteins that are of potential interest to the market often results in their self-assembly into amyloid-like structures in inclusion bodies (Ventura & Villaverde, 2006) . From a reversed biotechnological perspective, amyloid fibril formation is an im portant source of innovation, as huge numbers of new materials can be designed by exploiting the amyloid motif and the inherent diversity of protein sequences (cherny & gazit, 2008) .
in biology, the aggregation of peptides and proteins into both structured amyloid fibrils and more amorphous aggregates is a constant challenge for living organisms. to prevent, dedicated systems have evolved that range from inherent sequence and structural adaptations in natural proteins that directly inhibit their own aggregation, to more complex cellular machineries such as the heat-shock response, the unfolded-protein response, endoplasmicreticulum-associated degradation and autophagy, among others (Monsellier & chiti, 2007; Voellmy & Boellmann, 2007; Kapoor & Sanyal, 2009; Hoseki et al, 2009; Bejarano & cuervo, 2010) . the failure of proteins and peptides to remain soluble can result in pathology and many human diseases are associated with the formation of fibrillar aggregates: neurodegenerative conditions (such as alzheimer disease, parkinson disease and spongiform encephalopathies), systemic amyloidoses (such as light chain amyloidosis and dialysis-related amyloidosis), and localized amyloidosis (such as type 2 diabetes and atrial amyloidosis; chiti & Dobson, 2006) .
given the importance of amyloid fibril formation to protein chemistry, biotechnology, biology and medicine, it is important to elucidate the mechanisms by which proteins are converted from their soluble states into amyloid fibrils. in this context, improved knowledge of the structure of amyloid fibrils and the forces that promote and stabilize their formation has given rise to several mathe matical tools that allow the fundamental aspects of the aggregation process to be predicted. these include identifying the regions of the sequence of a protein that promote amyloid fibril formation and the effect of mutations.
the ability to predict amyloid fibril formation is important for several reasons in different scenarios. For biotechnology, accurately predicting aggregation allows the design of new proteins-or modified versions of existing ones-with properly modulated aggregation tendencies to avoid or enhance aggregation, depending on the intended application (Ventura & Villaverde, 2006; cherny & gazit 2008) . in medicine, many of the genetic diseases associated with fibril formation result from mutations in the sequence of the aggregating protein. therefore, the ability to predict the effect of mutations on the reviews re v iew propensity for amyloid formation also allows the elucidation of whether such mutations are pathogenic because they increase the inherent propensity of the associated protein to aggregate, or for other reasons (Sekijima et al, 2005) . From a protein-chemistry perspective, there is an interesting bonus arising from the development of increasingly accurate predictive tools: the factors on which the accurate tools are based must be relevant to amyloid formation and can therefore be flagged up for research in the field. in addition, the availability of computational tools should allow for the rapid and systematic analy sis of full proteomes, the comparison of categories of proteins and of proteins from different organisms, as well as the statistical analysis of strategies that have arisen to counteract aggregation throughout evolution (rousseau et al, 2006; Monsellier et al, 2008) .
The birth of predictive algorithms
the first mathematical tool shown to yield predictions consistent with in vitro experimental data was published in 2003 (chiti et al, 2003) . in this study, the aggregation rates of several singlepoint mutants of the model protein human muscle acylphosphatase (acp) were compared with those of the wild-type protein under the same conditions. the process for both wild-type and mutant acp was the conversion of tFE-denatured acp into β-sheet-containing, thioflavine-t-binding and congo-red-binding protofibrils. the change in the rate of aggregation of the mutants was found to correlate with changes in their hydrophobicity, propensity to form α-helical structure, propensity to form β-sheet structure at the site of the mutation, and overall charge. these intrinsic factors were combined to produce an empirical formula to predict the effect of a given mutation on the aggregation rate, as a function of the changes in these parameters after mutation. When tested on a range of mutants of different peptides and proteins (all unstructured or intrinsically disordered), the formula was found to yield accurate predictions. the algorithm was empirical and simple, but only valid for un structured peptides and proteins and only able to predict the effect of a given mutation on amyloid fibril formation or β-sheet aggregation generally, not on other observable factors. Despite its limitations, the formula paved the way for work based on the idea that amyloid fibril formation follows generic rules that can be rationalized.
today, approximately 14 computational tools have been published that aim to extend this predictive power to more difficult subjects (table 1). these include predicting the aggregation behaviour of initially folded proteins, as well as other observable characteristics of protein aggregation such as the absolute rate of amyloid fibril elongation or the aggregation-promoting regions within a given sequence.
the predictive models can be divided into two main cate gories: empirical and structure-based. Empirical tools try to explain experimental results and make predictions by identifying and considering the appropriate factors, either individually or in combination, mainly of the amino acid properties (for example, hydrophobicity, β-propensity and solubility). By contrast, models based on structure try to identify the determinants of amyloid aggregation by observing the existing three-dimensional (3D) structures of peptides that adopt a known fibrillar structure or native proteins that belong to distinct structural classes. 
Measurement of amyloid formation in vivo
all algorithms published so far have been inspired by and tested against experimental data obtained mainly in vitro, where the protein or peptide being studied aggregates in a buffered solution in the absence of other proteins or biological factors. However, amyloid formation phenomena that are relevant to biology, medicine and even biotechnology occur in complex biological environments. in such biological contexts, the presence of several agents has been shown to affect-often dramatically-protein aggregation. these agents include lipids, glycosaminoglycans, collagen fibres, molecular chaperones, proteases, apolipoprotein E, the serum amyloid p component, metal ions and probably many other as-yetunidentified agents. the question thus arises whether the predictive power embodied in the existing algorithms can be extended to amyloid formation in a biological context, or whether it is limited to simplified in vitro systems. the answer to this question is not trivial, particularly because the quantitative measurement of the aggregation rates or propensities of proteins in vivo is technically challenging. nevertheless, several papers have been published with data describing the aggregation propensities of wild-type and mutated proteins in Escherichia coli (Wurth et al, 2002; Kim & Hecht, 2006; de groot et al, 2006; Winkelmann et al, 2010) . these four reports use two techniques to detect aggregates in the E. coli cytosol. the first technique is based on the observation that gFp can be used as a reporter for protein aggregation, as its structure is de stabilized-and its associated fluorescence intensity is reducedif the protein fused to its amino-terminus is aggregated (Wurth et al, 2002) . By directly measuring the total fluorescence of the bacterial culture, the authors were able to determine the levels of aggregation of several variants of the aβ 42 peptide in a quantitative, rapid and inexpensive manner. in the second approach, single-point mutants of the HypF-n protein-all truncated at the carboxy-terminus to Each graph reports the predicted change in the aggregation propensity after mutation (calculated according to the algorithm indicated in each graph and following the procedure described in the supplementary information online) compared with experimental relative fluorescence of GFP fused to Aβ 42 mutants in E. coli cytosol, as described previously (de Groot et al, 2006) . A value of 0 on the y-axis corresponds to a value of 1 on the x-axis (no change, relative to wild type). Scales on the y-axis have been adjusted to show, for each plot, the full data set. The lines represent the best fits of the data to linear functions. For each plot, the name of the algorithm used is reported, as well as the absolute value of the Pearson linear correlation coefficient (r) and the statistical significance of the slope (p). Aβ 42 , 42-residue-long amyloid-β peptide; GFP, green fluorescent protein.
▶ reviews re v iew prevent folding-were expressed under strict, low-level expression conditions (Winkelmann et al, 2010) . the authors were able to produce at the desired time very low levels of mutated HypF-n (only detectable by western blotting) in order to preserve the original cellular machinery dedicated to the maintenance of protein homeostasis. By using this system, the authors were able to quantify the ratio of protein in the supernatant and pellet fractions (i Sn /i p ) for each expressed variant-a quantitative inverse correlate of the fraction of protein aggregating in vivo.
Both of these methods rely on the accumulating evidence that bacterial inclusion bodies consist of amyloid-like material as a result of the misfolding and aggregation of cytoplasmic proteins (carrió et al, 2005; Wang, l. et al, 2008) . Both methods are based on the quantitative measurement of mutant protein levels in inclusion bodies relative to wild type. they cannot determine absolute aggregation rates of expressed proteins or aggregation-promoting regions, but can quantitatively determine the effect of a given mutation on the propensity to form amyloid-like fibrils for a given protein expressed in vivo.
Predictions correlate with aggregation in vivo
this ability to monitor amyloid formation in E. coli allows the assessment of the rules and algorithms determined or generated from in vitro studies. this is achieved by applying the predictive algorithms to the data sets generated from the expression of mutants in vivo and comparing the predictions with the corresponding propensities to form inclusion bodies determined experimentally.
For the same group of aβ 42 variants (those of de groot et al, 2006) , Fig 1 shows plots of the change in the aggregation propensity predicted to result from mutation, against the measured fluorescence intensity of the fused gFp protein, where high fluorescence indicates low aggregation of aβ 42 . all 12 plots in Fig 1 use the same set of experi mental data on the x-axis, but different sets of predicted values on the y-axis. Each plot refers to a well-defined algorithm listed in table 1. excluding DuBay et al (2004) , which is redundant with respect to pawar et al (2005) , and BEtaScan, which could not provide quantitative values suitable for the analysis. For those algorithms for which the method used to predict the effect of a given mutation on aggregation was not explained in the original report, the pro cedure we used to determine the predicted change in aggregation propensity of aβ 42 following mutation, as well as the rationale behind the comparison with experimental parameters, are described in the supplementary information online. For the HypF-n mutants-those of Winkelmann et al (2010) -Fig 2 show plots of the predicted change in the aggregation propensity after mutation, against the solubility of Each graph reports the predicted change in the aggregation propensity after mutation (calculated according to the algorithm indicated in each graph and following the procedure described in the supplementary information online) compared with experimental solubility in E. coli cytosol (I SN /I P ) of the mutants of HypF-N, as described previously (Winkelmann et al, 2010) . A value of 0 on the y-axis corresponds to a value of 0.5 on the x-axis (no change, relative to wild type). Scales on the y-axis have been adjusted to show, for each plot, the full data set. The lines represent the best fits of the data to linear functions. For each plot, the name of the algorithm used is reported, as well as the absolute value of the Pearson linear correlation coefficient (r) and the statistical significance of the slope (p). 
Comparison between algorithms
among the algorithms considered in this review, those initially designed to generate aggregation-propensity profiles and identify aggregation-prone regions (table 1; supplementary table 1) were not optimized to determine the effect of mutations, so a direct comparison with algorithms that aim to predict the effect of mutations on aggregation rates or propensity does not favour them. in addition, only four experimental data sets containing quantitative determination of amyloid-like aggregation in vivo are available so far. all are in E. coli and three involve the same peptide. For these reasons, it is not appropriate to rank the accuracy and reliability of the algorithms on the basis of a comparison of the r and p values as determined when they are applied to the same set of experimental results (Fig 3) . nevertheless, we believe that the general comparative stra tegy is useful for this review, in order to provide an overview of the predictive power of in vivo amyloid aggregation.
the 3D-profile method is the only algorithm that produces predictions that correlate poorly with all four experi mental data sets. if we therefore exclude the 3D-profile method from the comparison, both empirical and structure-based algorithms perform similarly in predicting amyloid aggregation in vivo, confirming the validity of both approaches (mean r values of 0.631 ± 0.107 and 0.527 ± 0.136, respectively; median values of 0.622 and 0.522, respectively).
it is worth noting that algorithms that mark a neat distinction between aggregation-promoting regions and non-influential regions are not more accurate than those that do not consider the position of the mutated residue in the sequence. indeed, the experimental data reviewed here show that mutations have an effect on aggregation propensity in vivo at many positions in the sequence. taken together, this implies that the position of the mutation is not an important factor in amyloid formation in vivo. this might reflect the ability of chape rones to interact with and suppress the aggregation potential of hot spots, forcing other regions to emerge in promoting the process. it might also reflect the ability of the many biological macromolecules described so far to affect and nucleate amyloid fibril formation by promoting heterogeneous mechanisms of amyloid formation, on the basis of interactions that change with the biological factors involved and do not necessarily involve hot spots. Further investigation is needed to clarify this point.
Algorithms can predict disease manifestation
So far we have described the use of algorithms to predict amyloid formation in vitro and in the cytosol of E. coli-a simple organism in which the solubility or aggregation of an expressed peptide or protein can be measured quantitatively. now, the question is whether this reliability and accuracy can be extended to predicting amyloid fibril formation in superior organisms. in the context of medicine, can the algorithms be used to gain an understanding of the pathogenesis of protein deposition diseases in humans, for example to predict disease severity from the mutations associated with familial forms of a disease? the zyggregator algorithm-one of the 14 algorithms listed in table 1 and applied to the E. coli data in Figs 1, 2, S1 and S2-has been used to rationalize phenotypic effects of the aggregation of aβ 42 in the central nervous system of flies (luheshi et al, 2007) . in a group of Drosophila melanogaster strains overexpressing variants of aβ 42 , a strong negative correlation was found between the longevity and locomotor ability of the flies and the predicted propensity of the variants to form amyloid fibrils, as determined by using zyggregator (Fig 4a,B) . this result is remarkable for two reasons: first, it demonstrates the power of a computational method based on physicochemical factors to predict amyloid formation in an animal model; second, the prediction extends to the phenotypic effect of amyloid formation, thereby extending the predictive power beyond protein aggregation per se.
in the light of increasing understanding that protein oligomers or protofibrils (as opposed to fibrils) are the pathogenic species Experimental data by de Groot et al, 2006 Experimental data by Winkelmann et al, 2010 Experimental data by Wurth et al, 2002 Experimental data by Kim et al, 2006 Fig 3 | Correlation between the change in aggregation propensity observed in vivo and the change in aggregation propensity predicted in silico by algorithms. For each algorithm and each data set, the absolute value of the Pearson linear correlation coefficient (r) is reported as both a numeric value and a horizontal bar. reviews re v iew in neurodegenerative diseases associated with amyloid deposition, the authors of the same study used a modified version of the zyggregator algorithm to predict the effect of mutations on protofibril, rather than fibril, formation. the modified algorithm predicted the propensity of aβ 42 mutants to form protofibrils that better correlated with the relative longevity and locomotor ability of the flies expressing the same mutants (Fig 4c,D) , thus validating the power of algorithms adjusted to predict oligomer formation in medicine.
in another study, disease duration in patients with familial amyotrophic lateral sclerosis (falS), which is associated with mutations of superoxide dismutase 1 (SoD1), was found to negatively correlate with the increase in the rate of formation of β-sheet aggregates by SoD1 after mutation, as determined by using the chiti and Dobson equation (Fig 4E; Wang, Q. et al, 2008) . Dissimilarly to aβ 42 and truncated HypF-n, native SoD1 is a dimeric, folded protein containing secondary, tertiary and even quaternary structure. in a globular protein of this type, amyloid formation is known to require partial unfolding of the native structure and the amyloidogenic effect of a mutation is known to depend on the destabilization of the native structure caused by the mutation (chiti & Dobson, 2006) . Having observed that the disease duration of falS also negatively correlated with the instability of the SoD1 variants, the authors introduced a combined function to their algorithm that considered both the intrinsic propensity to form β-sheet aggregates of unfolded SoD1 (as determined using the equation from chiti & Dobson) and the instability of native SoD1 (Wang, Q. et al, 2008) . Disease duration was found to better correlate with such a combined function (Fig 4F) .
We have run all the algorithms on the aβ 42 variants in the Drosophila melanogaster study (luheshi et al, 2007) and on all SoD1 variants studied in the falS study (Wang, Q. et al 2008) . We found that some algorithms provide good predictions, whereas others fail to provide predictions of relative longevity and disease duration. as explained, the lower predictive power of the algorithms, in these cases relative to the E. coli studies, depends on the fact that phenotypic effects and clinical observations depend not only on amyloid formation, but also on other factors. the better performance of the modified algorithms used in the D. melanogaster and falS studies to consider the effect of mutations on protofibril formationrather than fibril formation-and protein instability, respectively, provide examples that this is the case.
A database to collect amyloid-formation data
to facilitate the development and testing of new algorithms (or improved versions of existing ones), it seems wise to create a database to collect experimentally determined kinetic data about oligomer or amyloid fibril formation. this database could then be used to analyse and compare data from different labs, involving different proteins, mutants and solution conditions. to this end, we have prepared a supervised, interactive web server for the deposition of kinetic data of oligomer or amyloid fibril formation and related experimental conditions, which we offer as a resource to the community. We have already deposited the data used in this review, and we encourage our peers to enrich the database with their own results at www.unifi.it/scibio/bioinfo/amyloBase.html. Can we dissect an algorithm into various forms that predict the different steps of aggregation (including rate of oligomerization, length of the lag phase for fibril formation, rate of fibril elongation, hot spots in oligomers and hot spots in fibrils)? (ii) Can we improve the existing algorithms with additional physicochemical and biological factors? (iii) How can we improve our ability to quantitatively measure protein aggregation and its various phases in vivo? (iv) Will we be able to discriminate between the factors affecting protein aggregation and its various phases in vitro or in vivo? Could we weight their contributions appropriately in both cases?
